Study analysis · The Journal of Physiology · 2018

Your muscles can shrink by 50% without you even moving—but here’s what surprises scientists.

When you don't move your muscles or have inflammation, your muscles shrink and your body can't use sugar well, but the causes are very different and not fully understood.

Reading level
Very low certainty
Level 2a · Systematic review of cohort studiesAssociation, not causationNo causal claims

Overview

What the study found

The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.

In simple terms

This study is like a book report where a scientist reads many other studies about how not moving or being sick can make muscles shrink and affect sugar levels. The scientist explains what other scientists found, but doesn't do any new experiments. So we can only say 'some studies suggest this might happen' and not 'this definitely causes that'.

What’s the bottom line?

When you don't move your muscles (like in a cast) or when your body has a lot of inflammation (like from an infection), your muscles can shrink and your body can have trouble using sugar properly. This review looks at how these two situations cause similar problems but through different chemical pathways inside the body.

How strong is this study?

Imagine your friend picks a few books from the library to tell you about muscle loss - but they didn't read every book on the topic or check if the books were good quality. This study is like that: it's a summary of some research, but we don't know if it's the full story. So we have to be careful when trusting what it says.

Reporting

40 / 100

  • COI disclosure+40/40
  • Data availabilitydata not shared
  • Code availabilitycode not shared
Methodology

0 / 100

  • Randomizationrandomization unclear
  • Blindingblinding unclear
  • Control groupno control group
  • Sample sizeno sample size reported
  • Follow-upno follow-up reported
Publication

100 / 100

Statistical

0 / 100

  • P-valuesno p-values reported
  • Effect sizeno effect size reported
  • Confidence intervalsno confidence intervals
  • Pre-registrationnot pre-registered

Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.

Where it sits

RCT reviews

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Reviews of Cohort Studies
Level 2a
1

1 / 100

Probability of being correct

Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.

This design cannot establish causation — the findings describe an association, not a cause. Narrative reviews synthesize existing literature without systematic methods, thus cannot establish cause-effect relationships. They provide expert interpretation but no new causal evidence.

No Conflicts

No conflicts of interest identified

Not Disclosed

No conflicts of interest or funding information were disclosed in the provided text.

Undisclosed — Suspicious

The text is a scientific review article without any disclosure of conflicts of interest, funding sources, or author affiliations. Therefore, no conflicts can be identified.

Key takeaways

  1. 01

    Immobilisation for 10 days can cut muscle protein building by about 50%.

  2. 02

    Inflammation can cause rapid muscle wasting in hospital patients.

  3. 03

    Both conditions affect how muscles use energy and build proteins.

  4. 04

    These findings are important for people who are bedridden or have severe infections, as muscle loss and insulin resistance can slow recovery.

Surprising findings

  • Muscle protein synthesis drops by 50% after 10 days of limb immobilisation, yet the Akt/mTOR pathway (thought to regulate synthesis) shows no change in phosphorylation.For decades, Akt/mTOR was considered the master regulator of muscle growth and atrophy, but this review shows it's not involved in human disuse atrophy.
  • In human immobilisation, muscle breakdown (proteolysis) plays a minor role in muscle loss—unlike in rodents, where breakdown dominates.This contradicts rodent studies that guide much of muscle biology. The review suggests fundamental metabolic differences between species.
  • A single signalling pathway (Akt/FOXO) can simultaneously cause both muscle atrophy and insulin resistance during inflammation.This molecular cross-talk means that insulin resistance and muscle wasting are not independent; they may be two sides of the same coin in inflammatory conditions.

Practical takeaways

If you are immobilised (e.g., in a cast), focus on strategies that stimulate muscle protein synthesis, such as consuming high-quality protein (e.g., 20-30g leucine-rich protein) soon after immobilisation, as the post-prandial increase is blunted.

The review notes that even high amino acid provision failed to rescue the anabolic response in the immobilised limb. Effectiveness may vary.

medium confidence

For critically ill patients with inflammation, early mobilisation (if safe) and nutritional support should target both muscle wasting and insulin resistance, as they share common molecular pathways.

Mechanistic understanding is still limited; interventions should be tailored and monitored.

low confidence

Avoid prolonged inactivity even without a cast—reduced ambulatory activity for 3-14 days can induce insulin resistance. Brief daily movement may mitigate this.

The exact mechanism is unclear, but the reduction in muscle contraction per se is key.

medium confidence

Why this study matters

10 days of immobility cuts muscle building by 50%

After just 10 days of limb immobilisation (like wearing a cast), the rate your muscle builds new protein drops by about 50%. This drop alone can explain the entire muscle loss you experience during that time, with breakdown playing only a minor role.

Most people think muscle loss from inactivity is due to breakdown, but this shows it's actually the building process that fails first.

The Akt/mTOR myth: It’s not the culprit for immobility atrophy

Despite popular belief, the famous Akt/mTOR pathway does NOT change in activity during immobilisation in humans. Even when muscle protein synthesis drops by 50%, phosphorylation of Akt and p70S6K remains normal. This suggests we still don’t know what really causes the shutdown.

This challenges years of textbook teaching and opens the door for new research.

Inflammation: Common end, different route

Inflammation (like from sepsis) triggers muscle wasting through a different molecular mechanism: cytokines like TNFα and IL-6 reduce Akt activity, which activates FOXO transcription factors, turning on genes like MAFbx and MuRF1 that break down muscle. This same pathway also causes insulin resistance.

This means treatments used for one type of muscle loss might not work for the other, and vice versa.

Muscle insulin resistance: It’s not just about fat

In immobility, insulin resistance develops within days and is linked to fat buildup inside muscle cells (IMCL) and reduced mitochondrial content. But the review stresses we don’t know if this fat is a cause or a consequence. In inflammation, insulin resistance is tied to the same Akt/FOXO signaling that drives muscle breakdown.

This suggests that not all insulin resistance is the same—context matters for treatment.

Want the whole report?

Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.